NCT00618046View on ClinicalTrials.gov

Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

November 30, 2004

Study Completion Date

November 30, 2004

Conditions
SeizuresEpilepsy
Interventions
DRUG

Oxcarbazepine

Trial Locations (1)

658902

Bio-Kinetics Clinical Applications, Inc ., Springfield

All Listed Sponsors
lead

Roxane Laboratories

INDUSTRY

NCT00618046 - Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions | Biotech Hunter | Biotech Hunter